Literature DB >> 23447694

Quantitative proteomic analysis for radiation-induced cell cycle suspension in 92-1 melanoma cell line.

Fengling Wang1, Zhitong Bing, Yanan Zhang, Bin Ao, Sheng Zhang, Caiyong Ye, Jinpeng He, Nan Ding, Wenling Ye, Jie Xiong, Jintu Sun, Yoshiya Furusawa, Guangming Zhou, Lei Yang.   

Abstract

Melanoma is a malignant tumor with high invasive and metastatic properties. Though radiation is the major therapy for melanoma, its radio-resistance has been shown to severely influence the clinical outcome. So it is imperative to enhance the sensitivity of uveal melanoma cells to radiotherapy. Previously, we found that the cell cycle of 92-1 uveal melanoma cells was suspended and remained unchanged for up to 5 days after exposure to 10 Gy of X-rays, which might be relevant to the high radio-sensitivity of 92-1 cells. To further investigate the cell cycle suspension-associated proteins, we employed two analyses with stable isotope labeling with amino acids in cell culture technology and two-dimensional liquid chromatography tandem mass spectrometry. Cells were incubated for 15 h or 48 h after irradiation with 10 Gy of X-rays. We identified a total of 737 proteins at 15 h (Group A) and 530 proteins at 48 h post-irradiation (Group B). The gene ontology biological pathway was used to obtain a systems level view of proteome changes in 92-1cells under cell cycle suspension. We further selected the significantly changed proteins for investigation of their potential contribution to cell cycle suspension, growth arrest and cell senescence. These proteins are involved in the cell cycle, stress response, glycolysis and the tricarboxylic acid cycle, etc. Our study expected to reveal potential marker proteins associated with cell suspension induced by irradiation, which might contribute to understanding the mechanism beyond the cell cycle suspension.

Entities:  

Keywords:  2D-LC-MS/MS; GO biological pathway; radiation; uveal melanoma

Mesh:

Substances:

Year:  2013        PMID: 23447694      PMCID: PMC3709680          DOI: 10.1093/jrr/rrt010

Source DB:  PubMed          Journal:  J Radiat Res        ISSN: 0449-3060            Impact factor:   2.724


INTRODUCTION

Melanoma is a malignant tumor with rapid metastasis and low levels of spontaneous apoptosis compared with other tumor cell types [1-3]. At present, radiotherapy has become the major treatment for most cases of uveal melanomas (UMs) [4, 5]. However, some UM cells are found to be radio-resistant to episcleral plaque charged-particle radiotherapy even at very high doses (85–100 Gy) [6-8]. In fact, data in vitro show that melanoma cells have high levels of damage repair at conventional fractionation doses and increased cell death with larger doses per fraction [9]. A defective p53 (TP53) gene may play a significant role in the radio-resistance of some human melanoma cell lines [10]. Some studies also showed that the melanoma cells were less sensitive to X-ray irradiation if they had a p16 mutation [11, 12]. Moreover, high doses of radiation can increase the risk of injury to normal tissues and lead to side-effects. So it is imperative to develop novel insights to enhance the sensitivity of UM cells to radiotherapy. Senescence of tumor cells can be induced by irradiation or chemotherapeutic drugs [13]. It has been demonstrated that senescent fibroblasts not only permanently exit from cell cycle traverse, but also resist cell death [14]. Generally, senescent cells are unable to override G1 arrest and have a late G1-phase DNA content [15]. In our previous study, we found that irradiation induced cell cycle suspension and the cell cycle distribution remained unchanged for up to 5 days in 92-1 uveal melanoma cells after exposure to 10 Gy of X-rays. Furthermore, the arrest cells displayed a senescence-like phenotype but there was no subsequent apoptotic cell death from 3 days after treatment [16]. This cell cycle suspension evidently contributes to the high radio-sensitivity of this cell line since it blocks cell division and growth. Thus, it is of great importance to identify cell cycle suspension-associated molecular markers. In recent years, two-dimensional liquid chromatography tandem mass spectrometry (2D-LC-MS/MS) has been generally used to detect a large quantity of proteins, which is important to aid understanding of complex molecular networks and allow investigation of the biological effects induced by irradiation [17-19]. More recently, combined analysis of proteomic and transcriptomic profiling have mainly concentrated on cutaneous melanomas [20]. Han and his colleagues employed liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis and identified 110 unique proteins in metastatic melanoma correlated with cell death, growth and tumorigenesis. In addition, most abundantly changed proteins were mapped to the cellular networks that are closely associated with the known oncogenes (JNK, c-myc and N-myc) and tumor suppressor genes (p53 and TGF -β) [21]. In this study, we employed 2D-LC-MS/MS, together with stable isotope labeling with amino acids in cell culture (SILAC), to quantitatively assess the changes in protein expression in 92-1 cells after 15 h and 48 h, respectively, of 10 Gy radiation. Our objective is to identify potential proteins contributing to radiation-induced cell cycle suspension in 92-1 cells.

MATERIALS AND METHODS

Cell culture

Human UM cell line (92-1) was kindly provided by Martine J. Jager and H. Monique H. Hurks (Leiden University Medical Center, Leiden, the Netherlands). For the forward SILAC experiments, the control cells were cultured in Dulbecco's Modified Eagle's Medium containing ‘heavy’ 13C615N4-L-arginine and 13C615N2-L-lysine, while 15 h and 48 h post-irradiation group cells were maintained in normal ‘light’ medium containing 12C614N4-L-arginine and 12C614N2-L-lysine. To improve the reliability of the experiment and reduce the probability of false positives, we exchanged labeling of isotopes between the control and the treatment. For reverse SILAC experiments, the cells cultured in the ‘heavy’ medium were treated with irradiation, whereas control cells were maintained in ‘light’ medium. All cells were kept in a humidified atmosphere of 95% air and 5% CO2 at 37°C. A total of 5 × 104 cells were seeded in 25 cm2 culture flasks for 2 days before irradiation, which resulted in < 70% confluence at the time the cells were irradiated. As a matter of convenience for quantitative analysis of the differences in protein expression level among the control group, the 15-h post-irradiation group and the 48-h group, we defined the 15-h post-irradiation group/control group as Group A, and the 48-h post-irradiation group/control group as Group B, respectively.

Irradiation

After 2 days of incubation, cells were irradiated at room temperature with 10 Gy of X-rays. The X-ray generator (Shimadzu, Tokyo, Japan) was operated at 200 kVp and 20 mA with 0.5 mm A1 and 0.5 mm Cu filters. The dose rate was 1 Gy/min. Then after 15 h or 48 h of further incubation, cells for SILAC assay were washed three times with pre-chilled phosphate buffered saline.

Sample preparation

Cells were suspended in 8 M urea and sonicated for cell lysis at 4°C. After centrifugation for 30 min at 20 000 g, the supernatants were collected and kept at–80°C for further analysis. Protein concentrations were measured using the Bradford method. Extracted protein samples from heavy and light were combined in a 1:1 ratio.

2D-LC-MS/MS analysis

The tryptic peptide mixtures were analyzed with 2D-LC coupled to a linear ion trap mass spectrometer LTQ-Orbitrap XL (Thermo Electron, San Jose, CA, USA). For each experiment, the peptide mixtures (from about 100 μg proteins) were pressure-loaded onto a biphasic silica capillary column (250 μm inner diameter) packed with 3 cm of C18 resin (SP-120-3-ODS-A, 5 µm; the Great Eur-Asia Sci&Tech Devolopment, Beijing, China) and 3 cm of strong cation exchange resin (SCX Luma, 5 µm, 100 Å; Phenomenex, Torrance, CA, USA). The buffers used were 0.1% formic acid (FA, buffer A), 80% acetonitrile (ACN)/0.1% FA (buffer B) and 600 mM ammonium acetate/5% ACN/0.1% FA (buffer C). Mass spectrum (MS) data were searched using the SEQUEST algorithm (Ver. 2.8) against the human database, which was released on 27 May 2008, and contains 37 869 protein sequences. The database was reversed and attached to estimate the false discovery rate (FDR). All searches were performed using a precursor mass tolerance of 3 Da calculated using average isotopic masses. Fixed modification was set for cysteine with the addition of 57.052 Da to represent cysteine carboxyamidation. Variable modification was set for methionine with the addition of 15.999 Da to represent methionine oxidation. Other variable modification for SILAC heavy labeling was set for arginine and lysine with the addition of 10.0083 Da and 8.0142 Da, respectively. A fragment ion mass tolerance of 1 Da was used. Enzyme cleavage specificity was set to trypsin and no more than two missed cleavages were allowed. The SEQUEST outputs were then analyzed using the commercial software Thermo Electron BioWorks (Rev. 3.3.1).

Data analysis and bioinformatic assay

The database was reversed and attached to estimate the false discovery rate (FDR). Bioworks was used to analyse and filter peptide identifications, i.e. Xcorr ≥1.8 (z = 1), 2.2 (z = 2), 3.5 (z = 3), Sp ≥500, Rsp ≥5, proteins with numbers of peptide ≥2 and Consensus score ≥10. An open source tool called trans-proteomic pipeline (Ver. 4.5.2) could perform these steps: PeptideProphet validates peptides assigned to MS/MS spectra [22], the automated statistical analysis on protein (ASAP) ratio program quantitates peptides [23] and proteins in differentially labeled samples and ProteinProphet [24] infers sample proteins. Quantification of each protein's relative expression for light and heavy labels was calculated using the ASAP ratio program. By default, the ASAP ratio was displayed as a ratio of heavy/light (ratio H/L) for SILAC experiments. ASAP ratio for the reverse experiment was the ratio of ‘heavy’ irradiated protein/'light' control protein, and the ASAP ratio for the forward experiment was the ratio of ‘heavy’ control protein/‘light’ irradiated protein. So, for forward SILAC analysis, the reciprocal of the ASAP ratio was usually used. A significant difference in protein expression was considered as >2 or <0.5. In addition, the minimum peptide length was considered as seven and the filtered out result was set at a PeptideProphet probability of 0.95. The PANTHER classification system was used for protein sorting (http://www.pantherdb.org) [25].

Western blot analysis

Cells were collected and lysed in appropriate amounts of lysis buffer (Biyuntian, Nanjing, China). Samples were centrifuged at 10 000 g, 4°C for 15 min and the concentration of total protein was determined from the supernatants using a bicinchoninic acid protein assay kit (Pierce, Rockford, IL, USA). Thereafter, samples were mixed with sample buffer (250 mM Tris HCl, 5% β-mercaptoethanol, 50% glycerol, 10% SDS, 0.5% bromophenol blue), boiled for 5 min and equal amounts of protein (30 μg) were separated with 10% SDS-PAGE gels (Bio-Rad, Tokyo, Japan). PVDF membranes (GE healthcare, Beijing, China) were rinsed in 100% methanol for 10 s and subsequently placed in transfer buffer (48 mM Tris, 39 mM Glycine, 0.037% SDS, 20% methanol) for 5 min. Blotting was performed at 120 V for 1.5 h in a wet transfer instrument (Bio-Rad, Hercules, CA, USA). The membranes were blocked for 1 h in blocking buffer (5% skim milk) and incubated with primary antibodies for 2 h (the primary antibodies to Ku70, Ku80 and β-actin were purchased from Santa Cruz). The membranes were then washed three times with phosphate buffered saline containing 0.1% Tween20 and incubated with secondary antibody for 1 h. Finally, following washing of the membranes, protein bands were visualized using the enhanced chemiluminescence system (Amersham-Buchler, Braunschweig, Germany) and exposed to X-ray medical film (Kodak, Tokyo, Japan).

RESULTS

We employed SILAC technology and 2D-LC-MS/MS to quantify radiation-induced differential protein expression in 92-1 cells. An overview of the workflow for quantitative analysis of protein expression is shown in Fig. 1. To obtain reliable results, both forward and reverse SILAC labeling were performed in Group A. Figure 2 shows the heat map for the proteins identified with changed expression levels in both forward and reverse SILAC experiments, which displays clearly repeatability in biological replicates. In addition, western blots were performed for two proteins including XRCC6/Ku70and XRCC5/Ku80 to validate the SILAC-MS results in both Group A and B. Western blot results of the two proteins at 15 h and 48 h post-radiation are shown in Fig. 3, and a comparison of the protein ratio obtained from the western blot and the SILAC-MS results is shown in Table 1.
Fig. 1.

The work flow of protein identification and quantification. For the SILAC experiments, the control cells were cultured in Dulbecco's Modified Eagle's Medium containing ‘heavy’ 13C615N4-L-arginine and 13C615N2-L-lysine, while irradiation group cells were maintained in normal ‘light’ medium containing 12C614N4-L-arginine and 12C614N2-L-lysine. The mixtures of Group A and Group B were analyzed by mass spectrum and then explained by SEQUEST.

Fig. 2.

Heat map generated from forward and reverse SILAC data in Group A. Reverse SILAC means that sham control cells were labeled with ‘light’ amino acids while irradiated cells with ‘heavy’ amino acids. Forward SILAC means that irradiated cells were labeled with ‘light’ amino acids while control cells were labeled with ‘heavy’ amino acids.

Fig. 3.

The expression level changes of XRCC5 and XRCC6 by western blot analysis at 15 h and 48 h post-irradiation.

Table 1.

Comparisons of the protein ratio obtained from western blots and SILAC-MS analysis

Protein nameNormalized ratio of western blot
Mean ASAP ratio of SILAC
15 h/Ctrl48 h/Ctrl15 h/Ctrl48 h/Ctrl
XRCC50.80 ± 0.210.68 ± 0.180.86 ± 0.240.49 ± 0.25
XRCC60.71 ± 0.190.66 ± 0.040.64 ± 0.540.77 ± 0.11

Gray intensity analysis for western blot was measured with Photoshop CS. The value was then normalized using the levels of β-actin. Average normalized value was presented from three independent experiments. MS = mass spectrum.

The work flow of protein identification and quantification. For the SILAC experiments, the control cells were cultured in Dulbecco's Modified Eagle's Medium containing ‘heavy’ 13C615N4-L-arginine and 13C615N2-L-lysine, while irradiation group cells were maintained in normal ‘light’ medium containing 12C614N4-L-arginine and 12C614N2-L-lysine. The mixtures of Group A and Group B were analyzed by mass spectrum and then explained by SEQUEST. Heat map generated from forward and reverse SILAC data in Group A. Reverse SILAC means that sham control cells were labeled with ‘light’ amino acids while irradiated cells with ‘heavy’ amino acids. Forward SILAC means that irradiated cells were labeled with ‘light’ amino acids while control cells were labeled with ‘heavy’ amino acids. The expression level changes of XRCC5 and XRCC6 by western blot analysis at 15 h and 48 h post-irradiation. Comparisons of the protein ratio obtained from western blots and SILAC-MS analysis Gray intensity analysis for western blot was measured with Photoshop CS. The value was then normalized using the levels of β-actin. Average normalized value was presented from three independent experiments. MS = mass spectrum. To remove false positive identifications, we excluded single peptide and non-applicable quantitative proteins. A total of 737 proteins were unambiguously identified in Group A, of which 290 proteins were down-regulated more than two-fold while 86 were up-regulated more than two-fold. In Group B, 530 proteins were identified, among which 97 and 78 were down- and up-regulated more than two-fold, respectively. Details of all quantified proteins can be found in Supplementary Table 1 and Supplementary Table 2. The distribution of changes in protein expression levels induced by X-ray irradiation is displayed in Fig. 4A. The proteins identified could be separated into five groups: proteins whose level decreased ≥2-fold (ASAP Ratio ≤0.5), decreased between 1.25- and 2-fold (0.5 < ASAP Ratio ≤ 0.75), increased ≥2-fold (ASAP Ratio ≥ 2), increased between 1.25- and 2-fold (1.25 ≤ ASAP Ratio < 2), and unchanged (0.75 < ASAP Ratio < 1.25) [26-27].
Fig. 4A.

Distribution of protein ASAP ratio (irradiated/control) for the quantified proteins in Group A and Group B. The distribution of proteins quantified by ASAP ratio and the threshold of fold change was cut off ± 1.25.

Partial list of the overlap proteins identified with more than two-fold changes in one SILAC experiment at least In Table 2, ‘0’ indicates that the peptides were not detected in the irradiated cells, but ‘999’ indicates that the peptides were not detected in the control cells. TCA = tricarboxylic acid.
Table 2.

Partial list of the overlap proteins identified with more than two-fold changes in one SILAC experiment at least

NP numberProtein nameGene name15 h mean ASAP ratio48 h mean ASAP ratio
Cell cycle-related proteins
NP_036457.1microtubule-associated proteinMAPRE10.470.17
NP_001099008.1Myb-binding protein 1AMYBBP1A3.540
NP_631946.1nucleosome assembly protein 1-like 1NAP1L10.320.73
NP_005960.1nucleosome assembly protein 1-like 4NAP1L40.180
NP_002625.1Prohibitin 1PHB10.690.41
NP_009204.1prohibitin 2PHB20.880.1
NP_008835.5DNA-dependent protein kinase catalytic subunitPRKDC0.670.74
NP_002806.2proteasome 26S non-ATPase subunit 11PSMD110.330.82
NP_002802.226S proteasome non-ATPase regulatory subunit 7PSMD70.480.82
NP_005611.1Protein S100-A11S100A110.770.54
NP_005110.2thyroid hormone receptor associated protein 3THRAP30.670.42
NP_003395.114-3-3 protein beta/alphaYWHAB0.330.18
NP_006752.114-3-3 protein epsilonYWHAE0.620.33
NP_056060.2Ankyrin repeat and SAM domain-containing protein 1AANKS1A1.040.47
Immune system process-related proteins
NP_003320.2ThioredoxinTXN0.350.04
NP_110437.2Thioredoxin domain-containing protein 5TXNDC50.550.45
NP_054817.2peroxiredoxin 3PRDX30.360.36
NP_036226.1peroxiredoxin 5PRDX50.580
NP_057376.2TNF receptor-associated protein 1TRAP14.040.49
NP_006358.1adenylyl cyclase-associated proteinCAP10.670.53
NP_000601.3CD44 antigenCD440.530.56
NP_002005.1FK506-binding protein 4FKBP40.250.41
NP_003290.1heat shock protein 90kDa betaHSP90B10.560.9
NP_005337.2Heat shock 70 kDa protein 1A/1BHSPA1B0.530
NP_006588.1heat shock 70kDa protein 8HSPA80.410.33
NP_004125.3heat shock 70kDa protein 9HSPA90.730.51
NP_001531.1heat shock 27kDa protein 1HSPB10.712.05
NP_002147.2heat shock protein 60 kDaHSPD10.540.43
NP_006635.2heat shock protein 105 kDHSPH10.821.18
NP_002297.2galectin 3LGALS30.670.56
NP_110437.2X-ray repair cross-complementing protein 5XRCC5/ku860.860.49
NP_001460.1X-ray repair cross-complementing protein 6XRCC6/ku700.640.77
Glycolysis-related proteins
NP_002037.2glyceraldehyde-3-phosphate dehydrogenaseGAPDH0.301.8
NP_002291.1lactate dehydrogenase BLDHB0.541.53
NP_000166.2glucose phosphate isomeraseGPI0.681.24
NP_000282.1phosphoglycerate kinase 1PGK10.621.1
NP_000356.1Triosephosphate isomeraseTPI10.651.09
NP_005557.1lactate dehydrogenase ALDHA0.561.01
NP_002645.3pyruvate kinasePKM20.640.83
NP_001419.1enolase 1ENO10.390.53
NP_908930.1aldolase AALDOA0.390.43
TCA cycle and electron transport chain proteins
NP_061820.1cytochrome cCYCS0.300.96
NP_000099.2dihydrolipoamide dehydrogenaseDLD0.46999
NP_001089.1aconitase 2ACO20.342.63
NP_004159.2succinate dehydrogenase complex, subunit ASDHA0.892.06
NP_001087.2ATP citrate lyase isoform 1ACLY0.601.68
NP_036475.3nicotinamide nucleotide transhydrogenaseNNT0.711.33
NP_000134.2fumarate hydrataseFH0.471.04
NP_005909.2mitochondrial malate dehydrogenaseMDH20.410.87
NP_004994.1Acyl carrier proteinNDUFAB10.302.89
NP_003356.2Cytochrome b-c1 complex subunit 1UQCRC10.660.92
NP_001677.2ATP synthaseATP5B0.610.85
NP_003357.2Cytochrome b-c1 complex subunit 2UQCRC20.570.83
Other
NP_001015.1ribosomal protein S21RPS210.900.23
NP_000979.1ribosomal protein L27RPL270.550.38
NP_056474.2ribosomal L1 domain containing 1RSL1D10.400.41
NP_000958.1ribosomal protein L3RPL30.880.44
NP_002286.2ribosomal protein SARPSA0.870.51
NP_150254.1ribosomal protein L13RPL131.480.55
NP_006351.2eukaryotic translation initiation factor 3EIF3M0.590.86
NP_001016.1ribosomal protein S23RPS230.470.89
NP_001408.2eukaryotic translation initiation factor 4BEIF4B0.450.9
NP_004437.2glutamyl-prolyl tRNA synthetaseEPRS0.480.91
NP_001002.1ribosomal protein S7RPS70.620.94
NP_000959.2ribosomal protein L4RPL40.681.08
NP_004085.1Eukaryotic translation initiation factor 2 subunit 1EIF2S10.101.13
NP_002939.2ribosomal protein L15RPL150.341.19
NP_444505.1ribosomal protein P0RPLP00.171.55
NP_000996.2ribosomal protein S3RPS30.531.59
NP_000960.2ribosomal protein L5RPL50.373.65
NP_001393.1Elongation factor 1-alpha 1EEF1A10.500.27
NP_001395.1Elongation factor 1-gammaEEF1G0.601.29
NP_006102.2acetyl-coenzyme A acyltransferase 2ACAA20.840.45
NP_005989.3chaperonin containing TCP1, subunit 3CCT30.301.32
NP_036205.1chaperonin containing TCP1, subunit 5CCT50.501.43
NP_001753.1chaperonin containing TCP1, subunit 6ACCT6A0.600.91
NP_006420.1chaperonin containing TCP1, subunit 7CCT70.39999
NP_006576.2chaperonin containing TCP1, subunit 8CCT80.670.56
NP_005498.1cofilin 1CFL10.230.9
NP_004081.1dual specificity phosphatase 3DUSP30.030.06
NP_004437.2glutamyl-prolyl tRNA synthetaseEPRS0.480.91
NP_006699.2glyoxalase IGLO10.491.07
NP_001035807.1Histone H2A type 2-AHIST2H2AA40.430.95
NP_036350.2Interleukin enhancer-binding factor 3ILF30.273.65
NP_002406.1macrophage migration inhibitory factorMIF0.371.02
NP_005372.2nucleolinNCL0.160.86
NP_683877.1proteasome alpha 1 subunitPSMA10.580.98
NP_002788.1proteasome beta 5 subunitPSMB50.624.13
NP_006494.1proteasome 26S ATPase subunit 4PSMC40.540.77
NP_002806.2proteasome 26S non-ATPase subunit 11PSMD110.330.82
NP_002825.3protein tyrosine phosphatase, non-receptor type 11PTPN110.221.95
NP_006316.1ras-related nuclear proteinRAN0.540.51
NP_005057.1splicing factor proline/glutamine richSFPQ0.781.71
NP_004243.1solute carrier family 9SLC9A3R10.000.36
NP_005753.1tripartite motif-containing 28 proteinTRIM280.470.77
NP_003339.1ubiquitin-conjugating enzyme E2NUBE2N0.492.55

In Table 2, ‘0’ indicates that the peptides were not detected in the irradiated cells, but ‘999’ indicates that the peptides were not detected in the control cells. TCA = tricarboxylic acid.

These proteins were analyzed by gene ontology (GO) from the PANTHER Database (http://www.pantherdb.org/) for protein categorization according to biological process and molecular function. Classification of proteins in Group A and Group B is displayed in Fig. 4B. GO analysis of the biological process indicated that about 37%, 5.3% and 5.2% of proteins belonged to the metabolic process, cell cycle and immune system process categories, respectively. And proteins falling into molecular function categories of catalytic activity, translation regulator activity and transporter activity were 35%, 2% and 3%, respectively. Figure 4C shows the distribution of proteins down- or up-regulated by two-fold or more in each biological process. In Group A, the number of down-regulated proteins was obviously more than the number of up-regulated proteins in all biological processes, especially in metabolic processes, immune system processes, apoptosis, developmental processes and cell cycle at 15 h post-irradiation. Interestingly, in Group B, lots of down-regulated proteins changed to up-regulation, and some up-regulated and unchanged proteins showed continuous up-regulation at 48 h post-irradiation. GO analysis of the cellular process at 48 h post-irradiation indicated that the number of up-regulated proteins was larger than the down-regulated proteins in transport processes, cellular component organization, system processes and developmental processes.
Fig. 4C.

Distribution of proteins down- and up-regulated by two-fold or more in each biological process. The abbreviations in the graph are as follows: cell communication (CC), cellular process (CP), cellular component organization (CCO), system process (SP), response to stimulus (RS), developmental process (DP), metabolic process (MP), immune system process (ISP).

Fig. 4B.

Gene ontology (GO) analysis of the proteins identified in group A and Group B. Pie charts (A) and (C) show proteins classified on the basis of biological processes for Group A and Group B, respectively. Pie charts (B) and (D) show proteins classified according to molecular function for Group A and Group B, respectively.

Distribution of protein ASAP ratio (irradiated/control) for the quantified proteins in Group A and Group B. The distribution of proteins quantified by ASAP ratio and the threshold of fold change was cut off ± 1.25. Gene ontology (GO) analysis of the proteins identified in group A and Group B. Pie charts (A) and (C) show proteins classified on the basis of biological processes for Group A and Group B, respectively. Pie charts (B) and (D) show proteins classified according to molecular function for Group A and Group B, respectively. Distribution of proteins down- and up-regulated by two-fold or more in each biological process. The abbreviations in the graph are as follows: cell communication (CC), cellular process (CP), cellular component organization (CCO), system process (SP), response to stimulus (RS), developmental process (DP), metabolic process (MP), immune system process (ISP). Among the quantified proteins, 399 could be quantified in both Group A and B. To catalog our data for further analysis, we divided these differentially expressed proteins into eight categories: 79 proteins down-regulated in both Group A and B (down-down), 111 down-regulated in Group A but unchanged in Group B (down-unchanged), 72 down-regulated in Group A while up-regulated in Group B (down-up), 32 unchanged in Group A and up-regulated in B (unchanged-up), 20 unchanged in Group A but down-regulated in B (unchanged-down), 22 up-regulated in Group A while down-regulated in Group B (up-down), 25 up-regulated in A while unchanged in B (up-unchanged) and 25 proteins up-regulated in both Group A and B (up-up) (Supplementary Table 3). From the MS data, the proteins with significant changes in Group A and Group B were reserved to analyze the biological process. We selected proteins including down-down, down-up, up-down and up-up groups to analysis with database for annotation, visualization and integrated discovery [28, 29]. Supplementary Table 4 shows a complete list of the enriched GO biological pathways for proteins with differential expression levels. The biological pathways for proteins with down-regulated expression within 15 h and 48 h post-irradiation are mainly involved in cell redox homeostasis, translation elongation, regulation of programmed cell death and apoptosis, regulation of the cell cycle and chromatin assembly, etc. (Fig. 5A). Enriched biological pathways for proteins identified with down-up expression include the metabolism of glycolysis and oxidative phosphorylation, the tricarboxylic acid cycle, aerobic respiration and the citrate metabolic process (Fig. 5B). The biological pathways for proteins with up-down expression include translation, amino acid activation and the RNA metabolic process (Fig. 5C). Enriched biological pathways for proteins identified with up-regulated expression in 15 h and 48 h post-irradiation are mainly involved in protein transport, cellular protein localization, protein import into the nucleus and the fibrinolysis process (Fig. 5D). From Fig. 5A, we found the proteins down-regulated in 15 h and 48 h were closely associated with a series of important cellular events that include cell death and apoptosis. The down-down expression proteins would play vital roles in cell suspension. The detailed biological process chart is shown in Supplementary Fig. 1. Table 2 gives a partial list of overlap proteins that displayed significant changes in the expression level of Group A or B. These proteins may be more likely to play major roles in the cell cycle, metabolism, the immune system process and translation after treatment.
Fig. 5.

Enriched biological pathways for the overlap proteins identified in Group A and Group B. Different biological pathway terms for proteins with changed expression levels analyzed by Database for Annotation, Visualization and Integrated Discovery. (A) Biological pathway terms associated with down-regulated proteins at 15 h and 48 h post-irradiation (down-down) (B) Proteins with down-regulated expression at 15 h then unchanged or up-regulated at 48 h post-irradiation (down-up). (C) Proteins with up-regulated expression at 15 h then unchanged or down at 48 h post-irradiation (up-down). (D) Proteins with up-regulated expression in 15 h and 48 h post-irradiation (up-up). Selection of significantly enriched terms (Benjamini-Hochberg P < 0.01(–log (P-value) >2.0)) was shown.

Enriched biological pathways for the overlap proteins identified in Group A and Group B. Different biological pathway terms for proteins with changed expression levels analyzed by Database for Annotation, Visualization and Integrated Discovery. (A) Biological pathway terms associated with down-regulated proteins at 15 h and 48 h post-irradiation (down-down) (B) Proteins with down-regulated expression at 15 h then unchanged or up-regulated at 48 h post-irradiation (down-up). (C) Proteins with up-regulated expression at 15 h then unchanged or down at 48 h post-irradiation (up-down). (D) Proteins with up-regulated expression in 15 h and 48 h post-irradiation (up-up). Selection of significantly enriched terms (Benjamini-Hochberg P < 0.01(–log (P-value) >2.0)) was shown.

DISCUSSION

In a previous study, we showed that cell cycle suspension accompanied by G2 arrest was induced in 92-1 cells at 15 h after exposure to 10 Gy X-rays, and most cells gradually presented the features of cellular senescence but no subsequent apoptotic response in the 5 days following after irradiation [16] (the summarized result is shown in Supplementary Fig. 2). The primary goal of this study was to identify proteins that contribute to radiation-induced cell cycle suspension, which is relevant to the high radio-sensitivity of the 92-1 UM cell line. To obtain reliable quantification results, we conducted two biology replications and two technical replications. To screen the significantly changed proteins, we considered those proteins that greatly coincided in two experiments.

Radiation-induced down-regulation of cell cycle-related proteins

Ten-gray X-ray treatment led to a systematic down-regulation of several important proteins involved in the cell cycle, DNA replication and chromosome stability within 48 h post-irradiation (Fig. 5A, Table 2). MAPRE1/EB1 is a microtubule-associated protein that interacts with the colorectal adenomatous polyposis coli tumor-suppressor protein and plays important roles in regulating microtubule dynamics, cell polarity and chromosome stability [30]. As a transcription factor, the nuclear protein NAP1L1 is involved in chromatin assembly and DNA replication and is up-regulated in hepatoblastomas [31]. It has been suggested that nuclear NAP1L1 in dividing cells influences the expression of proliferative genes, and increased expression of NAP1L1 may be related to the progression of cell growth. NAP1L4 in neural stem cells can also contribute to the phenotype of higher cell proliferation observed in the Nap1L2 mutant [32]. In our study, NAP1L4 and NAP1L2 were down-regulated both 15 h and 48 h post-irradiation. S100A11 protein has been shown to be overexpressed in many different types of human cancer, indicating that S100A11 may be involved in growth enhancement, malignant progression of cancer cells, or both [33]. The S100A11 down-regulated by irradiation might be related to inhibited cell growth. The study indicated that depletion of THRAP3, the transcription mediator subunit of THRAP3/TRAP150, by two distinct siRNAs, caused cells to be more sensitive to killing by hydroxyurea (HU) treatment, which induces replication-fork stalling and DNA damage in the S phase [34]. THRAP3 is also found in a complex containing the proteins SNIP1, PNN, BCLAF1 and SKIIP, which regulates Cyclin D1 RNA stability [35]. Another important protein family, known as 14-3-3 protein, has often been found to enhance the activity of proteins with proliferative or survival functions, such as the Raf serine/threonine kinase family [36]. Taken together with our findings, suppression of cell proliferation and growth, DNA repair and chromosome stability through the down-regulation of these proteins would be necessary for cell cycle suspension in 92-1 cells after irradiation. Prohibitins are mainly localized in mitochondria and composed of two subunits, PHB1 and PHB2. These two proteins are assembled into a ring-like macromolecular structure at the inner mitochondrial membrane and implicated in diverse cellular processes: from mitochondrial biogenesis and function to cell death and senescence [37]. Cells deleted for PHB1 and PHB2 showed a roughened cell surface and prolonged cell cycle after fewer divisions compared with the wild type, indicating that the normal ageing process is accelerated in cells lacking the PHB complex [38]. Similarly, lack of PHB1 in endothelial cells resulted in increased levels of reactive oxygen species (ROS), associated with a phenotype resembling senescence [33]. In our previous study, a senescence-like phenotype was observed when cell cycle suspension was induced in 92-1 cells from the third day after being exposed to 10 Gy of rays [16]. Importantly, we observed significantly lower levels of PHB1 and PHB2 in 92-1 cells at 48 h post-irradiation, it was validated that cell senescence could be accompanied by a decreased expression of PHB proteins.

Radiation-induced down-regulation of immunity related proteins

We also observed many proteins involved in redox homeostasis and the stress response displaying a significant decrease in 92-1 cells within 48 h post-irradiation (Fig. 5A, Table 2). The data suggested that 10 Gy of X-rays induced a relatively high degree of oxidative damage of 92-1 cells corresponding to redox imbalance and a weak antioxidant defense system. One report about the effect of oxidative stress on the cell cycle reveals that increases in ROS-induced DNA damage are correlated with cell cycle arrest [39]. In mammals, PRDX3 and PRDX5 are targeted to hydrogen peroxide in the mitochondrial matrix, and this oxidant is implicated in the damage associated with ageing and a number of pathologies [40]. Significant decreases in expression level of TXN, TXNDC5, PRDX3 and PRDX5 were detected, which would probably cause a decline in the antioxidant defense systems and promote cell cycle arrest and senescence.

Alteration in the expression of glycolysis and TCA cycle-related proteins

Several enriched biological pathways from proteins identified with down-regulation at 15 h then unchanged or up-regulated at 48 h post-irradiation are related to the energy-producing metabolic pathway (Fig. 5B). Our data showed two major enzymatic steps in the tricarboxylic acid (TCA) cycle are mediated by aconitase (ACO2) and succinate dehydrogenase (SDHA), both of which have trends for up-regulation at 48 h post-irradiation (ASAP ratio 2.63, 2.06, respectively). Succinate dehydrogenase (complex II of the electron transfer chain (ETC), is the only enzyme that participates in both the TCA cycle and ETC [41]. The product of the TCA cycle is NAD+/NADH, which is involved in promoting cell survival through stimulation of mitochondrial Sir2 proteins [42]. Our data might support the hypothesis that the up-regulated proteins in the TCA cycle contribute to cellular survival through decreasing the damage of oxidative stress.

Radiation-induced alteration in the expression of other important proteins

In our study we detected several ribosomal proteins involved in translation, most of which were down-regulated or unchanged after irradiation. EEF1A1 is considered as a key factor during protein biosynthesis [43], and the protein can positively regulate cell proliferation and cell death [44, 45]. Significant down-regulation of this protein in our data would seem to suppress cell proliferation within 48 h post-irradiation. SFPQ has been shown to exhibit multiple functions in nucleic acid synthesis and processing, including RNA splicing, DNA unwinding, DNA repair and linking RNA transcripts with RNA polymerase II [46]. Lowery et al. show that loss of SFPQ gene function leads to increased cell death throughout the early embryo, suggesting that cell survival requires functional SFPQ protein [47]. The protein was unchanged at 15 h post-irradiation, but was up-regulated at 48 h, which might contribute to RNA transcription and cell survival. DUSP3, an endogenous inhibitor of several mitogen-activated proteins kinase, targets and inactivates ERK and JNK [48]. Continuous down-regulation of DUSP3 might also activate the JNK pathway to promote cell survival. This study demonstrates that quantitative proteomics using SILAC is a useful technique to identify potential protein targets and cellular pathways changes that occur with a cell cycle suspension in 92-1 cells after irradiation. We identified several key molecules participating in the regulation of cell cycle checkpoint and DNA replication, cell growth and senescence. There were significantly decreased levels of cell cycle- and stress response-related proteins that would synergistically suppress cell growth and proliferation and promote cell senescence. Additionally, cell cycle suspension induced by ionizing radiation was a combined effect of many proteins associated with the biological processes of the cell cycle, cell growth and cell survival (Fig. 6). However, some typical cell cycle proteins such as CDKs or cyclins were not shown in this study because of their lower abundance and dynamic modification. In whole proteome analysis, the peptides coming from proteins with lower abundance and dynamic modification were always covered by high abundance and stable peptides from digest proteins and were difficult to detect. Numerous signal pathways and comprehensive regulations participate in the formation of cell cycle suspension post-irradiation, so further studies will be carried out to reveal the proteins playing crucial roles in this regulation.
Fig. 6.

Probable mechanism of cell cycle suspension induced by ionizing radiation. In 15 h/Ctrl group, cell cycle arrest might induced by these down-regulated proteins. In 48 h/Ctrl group, apoptosis was not observed and cell suspension emerged. The significantly changed proteins might play a vital role in cell growth, cell senescence and cell survival.

Probable mechanism of cell cycle suspension induced by ionizing radiation. In 15 h/Ctrl group, cell cycle arrest might induced by these down-regulated proteins. In 48 h/Ctrl group, apoptosis was not observed and cell suspension emerged. The significantly changed proteins might play a vital role in cell growth, cell senescence and cell survival.

FUNDING

This work was supported by grants from the Major State Basic Research Development Program of China (973 Program, No. 2010CB834201), the Hundred Talent Program of the Chinese Academy of Sciences (No. 0760140BR0 and T No. 91026005) and the Foundation for Young Talents of Gansu [No. 1208RJYA013].
  47 in total

Review 1.  Genetic and environmental factors in cancer and neurodegenerative diseases.

Authors:  Lucia Migliore; Fabio Coppedè
Journal:  Mutat Res       Date:  2002-12       Impact factor: 2.433

2.  A statistical model for identifying proteins by tandem mass spectrometry.

Authors:  Alexey I Nesvizhskii; Andrew Keller; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2003-09-01       Impact factor: 6.986

Review 3.  The evolving role of radiation therapy in the management of malignant melanoma.

Authors:  Niloufer Khan; Mohammad K Khan; Alex Almasan; Arun D Singh; Roger Macklis
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-04-12       Impact factor: 7.038

4.  Aberrant regulation and function of wild-type p53 in radioresistant melanoma cells.

Authors:  K Satyamoorthy; N H Chehab; M J Waterman; M C Lien; W S El-Deiry; M Herlyn; T D Halazonetis
Journal:  Cell Growth Differ       Date:  2000-09

5.  Cellular radiosensitivity of primary and metastatic human uveal melanoma cell lines.

Authors:  Gerard J M J van den Aardweg; Nicole C Naus; Anette C A Verhoeven; Annelies de Klein; Gregorius P M Luyten
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-08       Impact factor: 4.799

6.  Transcriptional profiling in hepatoblastomas using high-density oligonucleotide DNA array.

Authors:  Toshihito Nagata; Yasuo Takahashi; Yukimoto Ishii; Satoshi Asai; Yayoi Nishida; Akiko Murata; Tsugumichi Koshinaga; Masahiro Fukuzawa; Minoru Hamazaki; Keiko Asami; Etsuro Ito; Hitoshi Ikeda; Hideo Takamatsu; Kenichi Koike; Atsushi Kikuta; Minoru Kuroiwa; Arata Watanabe; Yoshiyuki Kosaka; Hiroo Fujita; Munenori Miyake; Hideo Mugishima
Journal:  Cancer Genet Cytogenet       Date:  2003-09

Review 7.  Tumor cell senescence in cancer treatment.

Authors:  Igor B Roninson
Journal:  Cancer Res       Date:  2003-06-01       Impact factor: 12.701

Review 8.  Apoptosis and melanoma chemoresistance.

Authors:  María S Soengas; Scott W Lowe
Journal:  Oncogene       Date:  2003-05-19       Impact factor: 9.867

9.  Splicing and transcription-associated proteins PSF and p54nrb/nonO bind to the RNA polymerase II CTD.

Authors:  Andrew Emili; Michael Shales; Susan McCracken; Weijun Xie; Philip W Tucker; Ryuji Kobayashi; Benjamin J Blencowe; C James Ingles
Journal:  RNA       Date:  2002-09       Impact factor: 4.942

10.  PANTHER: a browsable database of gene products organized by biological function, using curated protein family and subfamily classification.

Authors:  Paul D Thomas; Anish Kejariwal; Michael J Campbell; Huaiyu Mi; Karen Diemer; Nan Guo; Istvan Ladunga; Betty Ulitsky-Lazareva; Anushya Muruganujan; Steven Rabkin; Jody A Vandergriff; Olivier Doremieux
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

View more
  6 in total

1.  Identify the signature genes for diagnose of uveal melanoma by weight gene co-expression network analysis.

Authors:  Kai Shi; Zhi-Tong Bing; Gui-Qun Cao; Ling Guo; Ya-Na Cao; Hai-Ou Jiang; Mei-Xia Zhang
Journal:  Int J Ophthalmol       Date:  2015-04-18       Impact factor: 1.779

2.  The Highlighted Role of GAPDH and Nitric-Oxide Synthase Regulator Activity in Proton Beam Irradiated Melanoma BLM Cells.

Authors:  Mohammad-Mehdi Zadeh-Esmaeel; Shabnam Shahrokh; Mona Zamanian Azodi; Nayebali Ahmadi
Journal:  J Lasers Med Sci       Date:  2019-12-01

Review 3.  Blood Biomarkers of Uveal Melanoma: Current Perspectives.

Authors:  Manuel F Bande Rodríguez; Beatriz Fernandez Marta; Nerea Lago Baameiro; Maria Santiago-Varela; Paula Silva-Rodríguez; María Jose Blanco-Teijeiro; Maria Pardo Perez; Antonio Piñeiro Ces
Journal:  Clin Ophthalmol       Date:  2020-01-20

4.  iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma Tumors.

Authors:  John W Crabb; Bo Hu; John S Crabb; Pierre Triozzi; Yogen Saunthararajah; Raymond Tubbs; Arun D Singh
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

5.  High and low doses of ionizing radiation induce different secretome profiles in a human skin model.

Authors:  Qibin Zhang; Melissa Matzke; Athena A Schepmoes; Ronald J Moore; Bobbie-Jo Webb-Robertson; Zeping Hu; Matthew E Monroe; Wei-Jun Qian; Richard D Smith; William F Morgan
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

6.  Proteomic analysis of effects by x-rays and heavy ion in HeLa cells.

Authors:  Zhitong Bing; Guanghui Yang; Yanan Zhang; Fengling Wang; Caiyong Ye; Jintu Sun; Guangming Zhou; Lei Yang
Journal:  Radiol Oncol       Date:  2014-04-25       Impact factor: 2.991

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.